Beijing Konruns Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The assessment of Beijing Konruns Pharmaceutical Co Ltd is assembled by All Street Sevva using advanced NLP. The webpage contains a Q&A section about Beijing Konruns Pharmaceutical Co Ltd. Check the bottom of the webpage for potential risks for Beijing Konruns Pharmaceutical Co Ltd based on sector, location and marketcap.
Beijing Konruns Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Beijing Konruns Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing Konruns Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing Konruns Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Beijing Konruns Pharmaceutical Co Ltd report the average age of the workforce?
Does Beijing Konruns Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Beijing Konruns Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Beijing Konruns Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Beijing Konruns Pharmaceutical Co Ltd offer flexible work?
Does Beijing Konruns Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing Konruns Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Beijing Konruns Pharmaceutical Co Ltd conduct supply chain audits?
Does Beijing Konruns Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing Konruns Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Beijing Konruns Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Beijing Konruns Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing Konruns Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Beijing Konruns Pharmaceutical Co Ltd disclose water use targets?
Does Beijing Konruns Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Beijing Konruns Pharmaceutical Co Ltd have a product recall in the last two years?
Does Beijing Konruns Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Beijing Konruns Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing Konruns Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Beijing Konruns Pharmaceutical Co Ltd disclose parental leave metrics?
Does Beijing Konruns Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Beijing Konruns Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing Konruns Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Beijing Konruns Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Beijing Konruns Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing Konruns Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing Konruns Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Beijing Konruns Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Beijing Konruns Pharmaceutical Co Ltd disclose its waste policy?
Does Beijing Konruns Pharmaceutical Co Ltd report according to TCFD requirements?
Does Beijing Konruns Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing Konruns Pharmaceutical Co Ltd disclose energy use targets?
Does Beijing Konruns Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing Konruns Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing Konruns Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.